← All diseases

Neuromuscular diseases

Becker muscular dystrophy (BMD)

An inherited muscle disease. The muscles weaken and waste away over time. It mostly affects boys and men. It progresses more slowly than the Duchenne type.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Neuromuscular diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

The disease is caused by a change in the DMD gene. This gene makes a protein called dystrophin, which protects the muscle fibers. In the Becker type, there is too little of this protein or it does not work fully. As a result, the skeletal muscles and the heart muscle are damaged over time.

Which symptoms can occur?

Symptoms often begin between the ages of 5 and 15, but they can also appear later. The course varies from person to person.

  • Slowly increasing weakness in the leg and hip muscles
  • Frequent falls, difficulty climbing stairs and getting up from the floor
  • Difficulty running and jumping
  • Walking on tiptoe
  • Weakening of the heart muscle, called cardiomyopathy
  • Curvature of the spine, called scoliosis
  • Tiredness and difficulty breathing

How is it diagnosed?

The doctor examines the muscles and nerves. CK, a muscle enzyme, is measured in the blood. The diagnosis is confirmed with a genetic test that looks at the DMD gene. If needed, a muscle biopsy, EMG and heart tests are done.

Treatment and care

There is not yet a treatment that cures the disease; new treatments are being researched. Care aims to control symptoms and protect quality of life. Staying active is recommended; long periods without movement can weaken the muscles. Physiotherapy helps maintain muscle strength. Mobility aids and a wheelchair make getting around easier. The heart is checked regularly; if needed, devices such as a pacemaker are fitted. Some doctors may recommend steroid treatment. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through X-linked recessive inheritance. This is why mostly boys are affected. An affected boy usually inherits the gene from his carrier mother. Sometimes the change appears for the first time in the child and does not come from the family. The daughters of an affected father will very likely carry the gene. Women who are carriers may have a risk of mild muscle weakness and heart problems. Genetic counselling helps the family understand the risk.

Source: MedlinePlus Genetics: Duchenne and Becker muscular dystrophy · MedlinePlus Medical Encyclopedia: Becker muscular dystrophy · NHS: Muscular dystrophy

Key facts

How common is it?
Prevalence: 1-9 per 100 000 (Europe)
How is it inherited?
X-linked recessive
When does it usually start?
Adolescence, Adulthood, Childhood, Older age
Gene(s) involved
DMD

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

For all rare diseases: Nadir Hastalıklar Federasyonu

Links checked on October 8, 2026.

Guides related to this disease

  • Home care and medical devices · Home health service, oxygen and respiratory device reports, wheelchairs and orthoses, power outage notification, emergency plan.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Becker dystrophy

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 4 active interventional studies for this disease. 1 is recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Neuromuscular diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:98895 · ICD-11 8C70.0

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.